
University Clinical Centre Tuzla published an updated notice on 6 November 2026 about medicines that the Federation of Bosnia and Herzegovina Health Insurance and Reinsurance Fund had not supplied to the institution by that date. The list names idarubicin, mitoxantrone, pemetrexed 500 mg and everolimus 10 mg.
The notice is a snapshot for the stated date and availability may change. Patients should not stop, postpone or alter treatment on their own. Before a scheduled visit, they should contact the responsible clinic or treating doctor to confirm the current position and any effect on their treatment plan.
Zdravo BiH does not provide individual medical advice. Use the official UKC Tuzla notice or contact the institution directly for the latest list and instructions.